ghsf3 | 20906
SF3B1 Mutations
Keywords
MDS, myelodysplastic neoplasia, Ring sideroblasts, syndrome myelodysplasia
| Material |
|
|
| Note |
There is a possibility of excess information occurring with this analysis. This will be communicated, unless it is noted otherwise when placing the order. | Since in rare cases there may also be indications of hereditary changes, the GUMG (Federal Law on Genetic Testing in Humans) provides for the patient to be informed accordingly (see www.viollier.ch/en/SGMG_consent). |
|
| Min. quantity | 1 mL | |
| Stability | 1 day / 18-25°C; 4 days / 2-8°C | |
| Duration | 5 days | |
| Frequency | 2 x per week | |
| Method | Next Generation Sequencing | |
| Price | CHF 954.90 | |
| Tariff | 954.90 TP |
Reference values
| Value | Sex |
|---|---|
| negative | f+m |